Ads
related to: bristol-myers- Contact Us
Find all the ways to reach us
for the information you need.
- Our Company
Learn about our mission and
the values that drive us.
- News
Stay current on all things Vertex
and discover the latest news.
- Our Unique Approach
See What Makes Us Unique
And How We Put Science First.
- Contact Us
Search results
Biotech faces a reckoning: 'We've lost our luster in cell therapies'
FierceBiotech· 6 days agoThis story is part one in a four-part series about cell therapy created by the Fierce Biotech team....
1st-Quarter Earnings Season Results, Expectations for 2024
GuruFocus.com via Yahoo Finance· 6 days agoAt the same time, weaker expectations for the noted sectors are primarily driven by the negative...
Unlocking Alzheimer’s: Memory Complaints Can Predict Biological Changes in the Brain
SciTechDaily· 6 days agoA study reveals that reports of memory decline by patients and partners were associated with the...
'Outstanding' 5 Year PFS With Lorlatinib in ALK+ NSCLC
Medscape· 3 days agoFive-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some experts question the use of crizotinib as the comparator drug.
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents
MedPage Today· 3 days agoChina-based trial may present a hurdle to FDA approval, however
Uncovering the Unique Needs of Veterans Diagnosed With Cancer
Benzinga· 4 days agoFlorida Cancer Specialists & Research Institute, LLC (FCS) recognizes the urgency in addressing disparities in care among the veteran oncology patient population when treatment is sought outside ...
Ikena cuts Hippo med, half of staff in latest reprioritization
FierceBiotech· 6 days agoIkena Oncology is again shrinking its herd and signaling a tough fight ahead as one of two assets, a...
Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial
MedPage Today· 3 days agoReplacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced...
Cell therapy reckoning: How to get cell therapies flying off-the-shelf
FierceBiotech· 4 days agoThis story is the final part of a four-part series about cell therapy created by the Fierce Biotech...
Novartis sues Maryland over law prohibiting restrictions on 340B drugs
Becker’s Hospital Review· 4 days ago"Novartis sues Maryland over new law restricting 340B drug pricing program, citing conflict with federal law and potential harm to constitutional rights."
Ads
related to: bristol-myers